«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

26卷

期数:

2020年03期

页码:

226-229

栏目:

临床医学

出版日期:

2020-06-10

文章信息/Info

Title:

Clinical study on the effect of serum gamma-glutamyl transpeptidase on long-term prognosis of patients with stable coronary artery disease

文章编号:

1006-8147(2020)03-0226-04

作者:

阎保伟¹; 万亮辉²; 曹路²; 沈秀云³; 金冬霞²; 胡越成²; 张敬霞²; 丛洪良²

（1.天津医科大学研究生院，天津300070；2.天津市胸科医院心内科，天津 300222；3.天津市黄河医院心内科，天津 300110）

Author(s):

YAN Bao-wei¹; WAN Liang-hui²; CAO Lu²;  SHEN Xiu-yun³;  JIN Dong-xia²;  HU Yue-cheng²;  ZHANG Jing-xia²;  CONG Hong-liang²

（1.Graduate School, Tianjin Medical University, Tianjin 300070, China；2.Department of Cardiology, Tianjin Chest Hospital, Tianjin 300222, China；3.Department of Cardiology, Tianjin Yellow River Hospital, Tianjin 300110, China)

关键词:

γ-谷氨酰转肽酶; 稳定性心绞痛; 队列研究; 不良心血管事件; Cox风险回归模型

Keywords:

gamma-glutamyl transpeptidase; stable coronary artery disease; cohort study; adverse cardiovascular events; Cox risk regression model

分类号:

R541

DOI:

-

文献标志码:

A

摘要:

目的：探讨血清γ-谷氨酰转肽酶（GGT）对稳定性心绞痛患者远期预后的影响。方法：使用2014-2018年在天津市胸科医院心内科登记住院的病例数据资料进行回顾性队列研究，共295例新发稳定性心绞痛患者纳入研究。以患者首次确诊冠心病的日期为观察起点，观察终点为出现终点事件或最后一次就诊日期。根据观察期间是否发生不良心血管事件（MACE）分为事件组和非事件组，并根据GGT四分位数将患者分为4组，使用Cox风险回归模型分析GGT对MACE的影响。结果：本次研究随访中位数为4.06年，共有86例（29.15%）冠心病患者发生MACE事件，事件组患者在入院时年龄、高血压比例、TC、LDL-C、ALT和GGT水平均高于无事件组，差异具有统计学意义（均P＜0.05）；不同冠状动脉病变程度的患者MACE发生率存在差异，且三支病变的患者GGT含量要高于双支病变和单支病变，差异具有统计学意义（P＜0.001）。多因素Cox回归分析显示，GGT（与≤25 U/L组相比，31 U/L＜GGT≤38 U/L和＞38 U/L组的HR分别为1.109、1.299）、年龄（与＜60岁相比，≥60岁的HR=1.683，95%CI：1.394~2.032）、高血压（HR=1.562，95%CI：1.201~2.032）、TC（HR=1.286，95%CI：1.079~1.533）对稳定性心绞痛患者远期发生MACE事件的影响均有统计学意义（P＜0.05）。结论：血清GGT水平升高与稳定性心绞痛患者MACE的发生有关，为进一步临床研究提供了理论依据。

Abstract:

Objective: To explore the effect of serum gamma-glutamyl transpeptidase(GGT) on the long-term prognosis of patients with stable coronary artery disease. Methods: A retrospective cohort study was conducted by using Tianjin Chest Hospital database during 2014-2018. A total of 295 patients with stable coronary artery disease were enrolled and followed until the earliest of outcome occurrence. Patients were divided into event group and non-event group according to whether adverse cardiovascular events (MACE) occurred during follow-up, and patients were also divided into four groups according to the quartiles of GGT. Cox proportional hazards regression model was used to analyze the effects of GGT on MACE. Results: The median follow-up of this study was 4.06 years, and a total of 86 patients (29.15%) with stable coronary artery disease had MACE events. Patients in the event group had higher levels of age, hypertension, TC, LDL-C, ALT and GGT than those in the non-event group(all P＜0.05). GGT levels of patients with three-vessel disease was higher than that of patients with double-vessel disease and single-vessel disease(all P＜0.001). Cox proportional hazards regression analysis showed that GGT (compared with ≤ 25 U/L group, the HR of 31 U/L < GGT≤38 U/L and > 38 U/L group was 1.109, 1.299, respectively), age (compared with ＜60 years old group, HR = 1.683 in≥60 years old group , 95% CI: 1.394-2.032), hypertension(HR=1.562, 95% CI: 1.201-2.032), TC(HR = 1.286, 95% CI: 1.079-1.533), which had statistical significance on the long-term MACE events in patients with stable coronary artery disease(P < 0.05). Conclusion: The increase of serum GGT level is related to the occurrence of MACE in patients with stable coronary artery disease, which provides a theoretical basis for further clinical studies.

参考文献/References:

[1] 鲁晓涵，郭健，王妍苏，等. 谷氨酰转肽酶与代谢综合征的相关性研究[J].中国慢性病预防与控制，2015，23(11):814
[2] Toshikuni N ， Asaji T ， Nakanishi Y ， et al. Elevated serum gamma-glutamyl transpeptidase levels and fatty liver strongly predict the presence of carotid plaque[J]. J Atheroscler Thromb， 2015， 22(10):1051
[3] Lee D S， Evans J C， Robins S J， et al. Gamma glutamyl transferase and metabolic syndrome， cardiovascular disease， and mortality risk - The Framingham Heart Study[J].Arterioscler Thromb Vasc Biol，2007，27(1): 127
[4] Tsai J，Ford E S，Li C， et al. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults[J].Addict Behav，2012，37(1):78
[5] 乔杰，宋艳红.谷氨酰转肽酶的研究进展[J]. 医学理论与实践，2019，32(5):651
[6] 尤巧英，斯徐伟，朱麒钱.血清γ-谷氨酰转肽酶和超敏C反应蛋白与2型糖尿病患者血糖控制的关系[J]. 中国慢性病预防与控制，2017，25(2):136
[7] 毛玉，徐文俊，宋浩明，等.血清γ-谷氨酰转肽酶与冠状动脉病变严重程度的相关性[J]. 中国动脉硬化杂志，2013，21(11):1013
[8] 张放，安浩君，李霞，等.冠心病患者血清γ-谷氨酰转肽酶水平与Gensini评分的相关性研究[J].中国全科医学，2014，17(35):4166
[9] Ruttmann E， Brant L J， Concin H， et al.Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163，944 Austrian adults[J]. Circulation， 2005， 112(14):2130
[10] Paolicchi A， Emdin M， Ghliozeni E， et al.Images in cardiovascular medicine.Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity[J]. Circulation，2004，109(11):1440
[11] Shankar A， Li J， Klein B E， et al. Serum gamma-glutamyl transferase level and peripheral arterial disease[J]. Atherosclerosis， 2008，199(1):102
[12] Emdin M， Passino C， Michelassi C， et al. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease[J]. Int J Cardiol，2009，136(1):80

相似文献/References:

备注/Memo

备注/Memo:

基金项目 天津市胸科医院院级资助项目（2018XKZ22）
作者简介 阎保伟（1984-），男，硕士在读，研究方向：心血管疾病的诊治与预防；通信作者：丛洪良，E-mail：hongliangcong@126.com。

常用功能

更新日期/Last Update: 2020-06-13